Company Filing History:
Years Active: 2024
Title: Renzo Alfini: Innovator in Immunogenic Conjugates
Introduction
Renzo Alfini is a notable inventor based in Siena, Italy. He has made significant contributions to the field of immunology through his innovative work on immunogenic conjugates. With a total of 2 patents, Alfini's inventions are paving the way for advancements in immunization techniques.
Latest Patents
Alfini's latest patents include "Immunogenic conjugates and use thereof" and "Multi-functionalized nOMV conjugates." The first patent focuses on the technology of conjugating native, non-detergent extracted outer membrane vesicles (nOMV) to antigens, forming nOMV-antigen conjugates. These conjugates are particularly useful for creating immunogenic compositions and immunization processes. The second patent involves the conjugation of nOMV to multiple antigens, resulting in multi-functionalized nOMV-antigen conjugated derivatives, which also serve important roles in immunogenic compositions and immunization.
Career Highlights
Renzo Alfini is currently associated with GlaxoSmithKline Biologicals SA, where he continues to develop innovative solutions in the field of immunology. His work is characterized by a commitment to enhancing the efficacy of immunization strategies through advanced conjugation techniques.
Collaborations
Alfini collaborates with esteemed colleagues such as Francesca Micoli and Allan James Saul, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Renzo Alfini's contributions to the field of immunology through his patents and collaborations highlight his role as a leading inventor. His work is instrumental in advancing immunization technologies, making a significant impact on public health.